Evidence map›Paper›PMID 33500618›Full record

ArticleInternational journal of nanomedicine2021

Eco-Friendly and Facile Synthesis of Antioxidant, Antibacterial and Anticancer Dihydromyricetin-Mediated Silver Nanoparticles.

Zhao Li, Iftikhar Ali, Jiying Qiu, Huanzhu Zhao, Wenya Ma, Aiying Bai, Daijie Wang, Jingchao Li

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Zhao LiShandong Analysis and Test Center, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250014, People's Republic of China.ORCID 0000-0002-9963-290X
Iftikhar AliShandong Analysis and Test Center, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250014, People's Republic of China.ORCID 0000-0002-5817-8800
Jiying QiuInstitute of Agro-Food Science and Technology, Shandong Academy of Agricultural Sciences, Jinan 250100, People's Republic of China.
Huanzhu ZhaoShandong Analysis and Test Center, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250014, People's Republic of China.
Wenya MaShandong Analysis and Test Center, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250014, People's Republic of China.
Aiying BaiJinan Municipal Center for Disease Control and Prevention, Jinan 250001, People's Republic of China.
Daijie WangShandong Analysis and Test Center, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250014, People's Republic of China.ORCID 0000-0002-2156-4548
Jingchao LiShandong Analysis and Test Center, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250014, People's Republic of China.
Qilu University of Technology · CNShandong Academy of Agricultural Sciences · CNShandong Center for Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDihydromyricetin (DMY), a natural flavonoid, has reportedly antibacterial, antioxidant, anticancer and other properties. In the present study, DMY was used as a reducing agent and stabilizer to synthesize silver nanoparticles (AgNPs), and the optimal conditions for its synthesis were studied. The DMY-AgNPs were investigated for their DPPH scavenging properties and their potential against human pathogenic and food-borne bacteria viz.

methodsThe dihydromyricetin-mediated AgNPs (DMY-AgNPs) were characterized by ultraviolet-visible spectrophotometer (UV-Vis spectra), scanning electron microscopy (SEM), transmission electron microscopy (TEM), dynamic light scattering (DLS), Fourier-transform infrared spectroscopy (FTIR), X-ray photoelectron spectroscopy (XPS), and X-ray powder diffraction (XRD). Antioxidant activity of DMY-AgNPs was determined by 1.1-diphenyl-2-picrylhydrazyl (DPPH) scavenging. The antibacterial activity was determined by 96-well plate (AGAR) gradient dilution, while anticancer potential was determined by MTT assay.

resultsThe results showed that the dispersion of AgNPs had the maximum UV-visible absorption at about 410 nm. The synthesized nanoparticles were almost spherical. FTIR was used to identify functional groups that may lead to the transformation of metal ions into nanoparticles. The results showed that the prepared AgNPs were coated with biological molecules in the extraction solution. The biosynthesized DMY-AgNPs exhibited good antioxidant properties, at various concentrations (0.01-0.1mg/mL), the free radical scavenging rate was about 56-92%. Furthermore, DMY-AgNPs possessed good antibacterial properties against

conclusionThe present study provides a green approach for the synthesis of DMY-AgNPs which exhibited stronger antioxidant, antibacterial and anticancer properties compared to the dihydromyricetin. DMY-AgNPs can serve as an economical, efficient, and effective antimicrobial material for its applications in food and pharmaceutical fields.

Indexed as

Anti-Bacterial AgentsAntineoplastic AgentsAntioxidantsBacteriaCell Line, TumorEscherichia coliFlavonolsHumansMetal NanoparticlesMicrobial Sensitivity TestsSilverSpectrophotometry, UltravioletX-Ray DiffractionAnti-Bacterial AgentsAntineoplastic AgentsAntioxidantsdihydromyricetinFlavonolsSilverDMY-AgNO3-NPsDPPHEscherichia coligreen approachHelaHepG2MDA-MB-231natural flavonoidSalmonella

Identifiers

PMID33500618
PMCPMC7826068
OpenAlexW3122331671

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.